A Study on siddha medicine (karunjeeeraga chooranam and silasathu parpa mathirai) for Hyperlipidemia among outpatients attending ayothidoss pandithar hospital

An Open Clinical trial to evaluate the therapeutic efficacy of selective Siddha medicine in the management of Hyperlipidemia among outpatients attending Ayothidoss Pandithar Hospital, National Institute Of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069396

Enrollment

Registered

2024-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Karunjeeraga Chooranam Silasathu Parpa Mathirai: Karunjeeraga Chooranam- 2 gms bd with honey for 48 days Silasathu Parpa Mathirai- 2 tabs bd with ghee for 48 days Control Intervention1:

Eligibility

Inclusion criteria

Inclusion criteria: 1.Increased levels of any one of the lipid profile according to WHO guidelines. 2.Patient who was already diagnosed as hyperlipidemia.

Exclusion criteria

Exclusion criteria: 1.Patients with chronic kidney diseases, cardiovascular diseases 2.Active vascular disease (e.g. unstable angina, stroke like symptoms) 3.Patients with known liver diseases. 4.Pregnancy and lactation ? Patients with any other serious illness

Design outcomes

Primary

Measure	Time frame
Reduction in values of lipid profile will be assessed before and after treatment.Timepoint: Reduction in values of lipid profile will be assessed after the period of 48 days.	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr H Vetha Merlin Kumari

National Institute of Siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026